Indications
Therapeutic Asset Ratings
13,145 results matching 1 filter
91,565
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Busulfanum
Mucopolysaccharidosis Type 7
Masonic Cancer Center, University of Minnesota
P2
B
(57)
Busulfanum
Sphingolipidosis
Masonic Cancer Center, University of Minnesota
P2
B
(57)
Byetta
Stroke Disorder
Christina Kruuse
P2
B
(57)
Cabergoline
Polycystic Ovary Syndrome
Al-Rasheed University College
P2
B
(57)
Cabozantinib
Breast Cancer
M.D. Anderson Cancer Center
P2
B
(57)
Cabozantinib
Carcinoid Tumor
Fox Chase Cancer Center
P2
B
(57)
Cabozantinib
Central Nervous System Neoplasm
National Cancer Institute (NCI)
P2
B
(57)
Cabozantinib
Chromophobe Renal Cell Carcinoma
Bradley A. McGregor, MD
P2
B
(57)
Cabozantinib
Cutaneous Melanoma
National Cancer Institute (NCI)
P2
B
(57)
Cabozantinib
Penile Carcinoma
National Cancer Institute (NCI)
P2
B
(57)
Cabozantinib
Uterine Corpus Cancer
M.D. Anderson Cancer Center
P2
B
(57)
Cagrilintide
Chronic Kidney Disease
Novo Nordisk A/S
P2
B
(57)
Capecitabine
Endometrial Cancer
Merck Sharp & Dohme LLC
P2
B
(57)
Capecitabine
Estrogen-Receptor Positive Breast Cancer
UNC Lineberger Comprehensive Cancer Center
P2
B
(57)
Capecitabine
Gallbladder Carcinoma
Seagen, a wholly owned subsidiary of Pfizer
P2
B
(57)
Capecitabine
Gastrin-Producing Neuroendocrine Tumor
ECOG-ACRIN Cancer Research Group
P2
B
(57)
Capecitabine
Ovarian Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Capecitabine
PPoma
ECOG-ACRIN Cancer Research Group
P2
B
(57)
Capecitabine
Rectal Disorder
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
B
(57)
Capecitabine
Pancreatic Endocrine Carcinoma
Alliance for Clinical Trials in Oncology
P2
B
(57)
Capecitabine
Urinary Bladder Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Capecitabine
Uterine Cervix Neoplasm
Merck Sharp & Dohme LLC
P2
B
(57)
Carfloglitazar Sodium
Metabolic Dysfunction-Associated Steatohepatitis
Chipscreen Biosciences, Ltd.
P2
B
(57)
Catequentinib
Chemotherapy-Induced Toxicity
Wenjun Cheng
P2
B
(57)
Catequentinib
Neoplasm
Sun Yat-sen University
P2
B
(57)
Showing 2951 to 2975 of 13,145 assets
Previous
Page 119 of 526
Next